日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation

台湾肿瘤消融学会制定的转移性肝肿瘤消融共识指南

Wu, Ming Shun; Kao, Wei-Yu; Chiang, Ming-Feng; Chuang, Po-Heng; Hsu, Shih-Jer; Wang, Shen-Yung; Chang, Ching-Wei; Lin, Chen-Chun; Hung, Chao-Hung; Wu, Chih Horng; Chen, San-Chi; Lee, Hsin-Lun; Hwang, Jen-I; Liang, Po-Chin; Lin, Shi-Ming; Wang, Chia-Chi

Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease

健康个体和处于不同阶段乙型肝炎病毒相关肝病患者肠道菌群的多样性和组成

Lin, Meng-Ju; Su, Tung-Hung; Chen, Chieh-Chang; Wu, Wei-Kai; Hsu, Shih-Jer; Tseng, Tai-Chung; Liao, Sih-Han; Hong, Chun-Ming; Yang, Hung-Chih; Liu, Chun-Jen; Wu, Ming-Shiang; Kao, Jia-Horng

Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease

更正:健康个体和处于乙型肝炎病毒相关肝病不同阶段的患者肠道菌群的多样性和组成

Lin, Meng-Ju; Su, Tung-Hung; Chen, Chieh-Chang; Wu, Wei-Kai; Hsu, Shih-Jer; Tseng, Tai-Chung; Liao, Sih-Han; Hong, Chun-Ming; Yang, Hung-Chih; Liu, Chun-Jen; Wu, Ming-Shiang; Kao, Jia-Horng

Ropeginterferon alfa-2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy

罗培干扰素α-2b治疗1型基因型慢性丙型肝炎患者:药代动力学、安全性和初步疗效

Lin, Hsien-Hong; Hsu, Shih-Jer; Lu, Sheng-Nan; Chuang, Wan-Long; Hsu, Chao-Wei; Chien, Rong-Nan; Yang, Sien-Sing; Su, Wei-Wen; Wu, Jaw-Ching; Lee, Tzong-Hsi; Peng, Cheng-Yuan; Tseng, Kuan-Chiao; Qin, Albert; Huang, Yi-Wen; Chen, Pei-Jer

Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B

每两周一次的罗培干扰素α-2b(Ropeginterferon alfa-2b)是一种新型聚乙二醇干扰素,用于治疗慢性乙型肝炎患者。

Huang, Yi-Wen; Hsu, Chao-Wei; Lu, Sheng-Nan; Yu, Ming-Lung; Su, Chien-Wei; Su, Wei-Wen; Chien, Rong-Nan; Hsu, Ching-Sheng; Hsu, Shih-Jer; Lai, Hsueh-Chou; Qin, Albert; Tseng, Kuan-Chiao; Chen, Pei-Jer

Safety of Perfluorobutane (Sonazoid) in Characterizing Focal Liver Lesions

全氟丁烷(Sonazoid)在局灶性肝脏病变鉴别诊断中的安全性

Chou, Yi-Hong; Liang, Ja-Der; Wang, Shen-Yung; Hsu, Shih-Jer; Hu, Jui-Ting; Yang, Sien-Sing; Wang, Hsin-Kai; Lee, Tien-Ying; Tiu, Chui-Mei

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients

慢性丙型肝炎患者肝细胞癌风险相关的临床疗效和治疗后血清标志物

Lee, Mei-Hsuan; Huang, Chung-Feng; Lai, Hsueh-Chou; Lin, Chun-Yen; Dai, Chia-Yen; Liu, Chun-Jen; Wang, Jing-Houng; Huang, Jee-Fu; Su, Wen-Pang; Yang, Hung-Chih; Kee, Kwong-Ming; Yeh, Ming-Lun; Chuang, Po-Heng; Hsu, Shih-Jer; Huang, Ching-I; Kao, Jung-Ta; Chen, Chieh-Chang; Chen, Sheng-Hung; Jeng, Wen-Juei; Yang, Hwai-I; Yuan, Yong; Lu, Sheng-Nan; Sheen, I-Shyan; Liu, Chen-Hua; Peng, Cheng-Yuan; Kao, Jia-Horng; Yu, Ming-Lung; Chuang, Wan-Long; Chen, Chien-Jen

High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments

抗病毒治疗可降低慢性丙型肝炎病毒感染患者血清中高脂多糖结合蛋白水平

Nien, Hsiao-Ching; Hsu, Shih-Jer; Su, Tung-Hung; Yang, Po-Jen; Sheu, Jin-Chuan; Wang, Jin-Town; Chow, Lu-Ping; Chen, Chi-Ling; Kao, Jia-Horng; Yang, Wei-Shiung

Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy

聚乙二醇干扰素联合利巴韦林治疗慢性丙型肝炎患者SCARB1基因多态性与病毒学应答的关系

Ching-Sheng Hsu, Shih-Jer Hsu, Wei-Liang Liu, Ding-Shinn Chen, Jia-Horng Kao

Pentablock copolymers of pluronic F127 and modified poly(2-dimethyl amino)ethyl methacrylate for internalization mechanism and gene transfection studies

Pluronic F127 和改性聚(2-二甲氨基)乙基甲基丙烯酸酯的五嵌段共聚物用于内化机制和基因转染研究

Huang, Shih-Jer; Wang, Tzu-Pin; Lue, Sheng-I; Wang, Li-Fang